{"id":5116,"date":"2026-02-09T09:30:48","date_gmt":"2026-02-09T09:30:48","guid":{"rendered":"https:\/\/cognitionconferences.com\/biotechnology\/?post_type=speaker&p=5116"},"modified":"2026-02-09T09:30:48","modified_gmt":"2026-02-09T09:30:48","slug":"amel-elbasyouni","status":"publish","type":"speaker","link":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/","title":{"rendered":"Amel Elbasyouni"},"content":{"rendered":"

Abstact<\/p>\n

<\/strong>Cervical cancer remains a leading cause of cancer-related mortality among women globally. Current therapeutic approaches primarily target single molecular pathways, often resulting in limited efficacy, drug resistance, and significant side effects. In this study, we developed novel multi-compound therapeutic platform for cervical cancer treatment, demonstrating superior efficacy compared to conventional single-target approaches. We employed computational network pharmacology analysis to identify eight bioactive compounds targeting key cervical cancer pathways including apoptosis, cell cycle regulation, angiogenesis, and metastasis. Mechanistic studies included assessment of selectivity, apoptosis, cell cycle, autophagy, pathway analysis, and gene expression profiling. Interestingly, the multi-compound formulation demonstrated significantly superior cytotoxic activity compared to conventional chemotherapeutic agents with enhanced selectivity for cancer cells over normal cells. The formulation induced intrinsic mitochondrial apoptosis via p53 and ER-stress, arrested cell cycle at G2\/M checkpoint and inhibited autophagy. The network analysis identified 564 key protein targets across 178 pathways related to cervical cancer. This multi-compound approach addresses critical limitations of current cervical cancer treatments by targeting multiple pathways simultaneously to reduce resistance potential. The formulation utilizes established compounds with known safety profiles which facilitates regulatory approval pathways. In conclusion, this therapeutic platform represents a significant advancement in cervical cancer treatment strategy with demonstrated synergistic efficacy, enhanced selectivity, and multi-pathway mechanism of action that facilitates its clinical translation. Current efforts focus on formulation optimization, standardization protocols, and IND-enabling studies to advance toward Phase I clinical trials.
\n<\/strong><\/p>\n","protected":false},"featured_media":5117,"template":"","meta":{"_acf_changed":false},"schedule":[],"speaker-category":[6],"class_list":["post-5116","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","speaker-category-speakers"],"acf":[],"yoast_head":"\nAmel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya<\/title>\n<meta name=\"description\" content=\"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya\" \/>\n<meta property=\"og:description\" content=\"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/\" \/>\n<meta property=\"og:site_name\" content=\"Cognition Conferences\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cognitionconferences.com\/biotechnology\/wp-content\/uploads\/2026\/02\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/\",\"name\":\"Amel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png\",\"datePublished\":\"2026-02-09T09:30:48+00:00\",\"description\":\"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png\",\"contentUrl\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png\",\"width\":500,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/speaker\\\/amel-elbasyouni\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amel Elbasyouni\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/#website\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/\",\"name\":\"Cognition Conferences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cognitionconferences.com\\\/biotechnology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya","description":"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/","og_locale":"en_US","og_type":"article","og_title":"Amel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya","og_description":"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.","og_url":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/","og_site_name":"Cognition Conferences","og_image":[{"width":500,"height":600,"url":"https:\/\/cognitionconferences.com\/biotechnology\/wp-content\/uploads\/2026\/02\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/","url":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/","name":"Amel Elbasyouni | Pan African University Institute for Basic Sciences, Technology & Innovation | Kenya","isPartOf":{"@id":"https:\/\/cognitionconferences.com\/biotechnology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/#primaryimage"},"image":{"@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/#primaryimage"},"thumbnailUrl":"https:\/\/cognitionconferences.com\/biotechnology\/wp-content\/uploads\/2026\/02\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png","datePublished":"2026-02-09T09:30:48+00:00","description":"Amel Elbasyouni has completed her PhD in Molecular Biology and Biotechnology at the Pan African University in 2025 at the age of 27 years. Dr. Amel Elbasyouni is a molecular biologist and biotechnologist advancing translational research in precision oncology. Her work translates molecular discoveries into therapeutic innovations, with a particular focus on identifying and validating novel biomarkers and drug targets for cancer treatment. She integrates molecular biology research with computational biotechnology to accelerate the development of therapeutic candidates. Her research bridges fundamental molecular understanding with clinical applications in oncology.","breadcrumb":{"@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/#primaryimage","url":"https:\/\/cognitionconferences.com\/biotechnology\/wp-content\/uploads\/2026\/02\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png","contentUrl":"https:\/\/cognitionconferences.com\/biotechnology\/wp-content\/uploads\/2026\/02\/Copy-of-Copy-of-Copy-of-Untitled-Design-25.png","width":500,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/cognitionconferences.com\/biotechnology\/speaker\/amel-elbasyouni\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cognitionconferences.com\/biotechnology\/"},{"@type":"ListItem","position":2,"name":"Amel Elbasyouni"}]},{"@type":"WebSite","@id":"https:\/\/cognitionconferences.com\/biotechnology\/#website","url":"https:\/\/cognitionconferences.com\/biotechnology\/","name":"Cognition Conferences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cognitionconferences.com\/biotechnology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/speaker\/5116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/speaker"}],"about":[{"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/types\/speaker"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/media\/5117"}],"wp:attachment":[{"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/media?parent=5116"}],"wp:term":[{"taxonomy":"schedule","embeddable":true,"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/schedule?post=5116"},{"taxonomy":"speaker-category","embeddable":true,"href":"https:\/\/cognitionconferences.com\/biotechnology\/wp-json\/wp\/v2\/speaker-category?post=5116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}